Product
Dinutuximab Beta
Name
Unituxin
INN Name
DINUTUXIMAB
FDA Approved
Yes
2 clinical trials
1 organization
2 indications
1 document
Indication
High-risk NeuroblastomaIndication
LeiomyosarcomaClinical trial
An Open-Label, Multi-Center, Single-Arm, Phase 1 Study Evaluating the Safety and Pharmacokinetics of Dinutuximab Beta as Maintenance Therapy in Chinese Patients With High-Risk NeuroblastomaStatus: Completed, Estimated PCD: 2023-06-28
Clinical trial
Combined Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Metastatic or Inoperable Leiomyosarcoma - DiTuSarc StudyStatus: Recruiting, Estimated PCD: 2024-07-26
Document
DailyMed Label: UnituxinOrganization
United Therapeutics Corporation